Cargando…
Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases
Siglec-15 is a member of the Siglec family of glycan-recognition proteins, primarily expressed on a subset of myeloid cells. Siglec-15 has been known to be involved in osteoclast differentiation, and is considered to be a potential therapeutic target for osteoporosis. Recent studies revealed unexpec...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941304/ https://www.ncbi.nlm.nih.gov/pubmed/31900164 http://dx.doi.org/10.1186/s12929-019-0610-1 |